🐝
What does the National Institute of Health (NIH) have to say about cannabis, various cannabinoids, and their effectiveness for a treatment option for Fibromyalgia?
🌲
Well, let’s find out!
♻️
According to the NIH, Fibromyalgia is a complex disease process that is not fully understood, and effective treatment is limited, but they did say exercise has a great impact (Berger et al., 2020).
🐝
Could the unknowns of this disease be because the Endocannabinoid System (ECS, the largest receptor system in the body) is absent from medical textbooks? You can’t fully understand something you do not know… anyways, let’s get back to it.
🌲
The NIH stated that Fibromyalgia can cause chronic pain, depressive mental status, fatigue all while increasing the cost of healthcare, reducing quality of life, and productivity (Berger, et al., 2020).
♻️
Since there were limited and effective treatment options, this pushes healthcare to search for alternative treatment options and the results are astonishing.
🐝
The ECS plays a role in maintaining homeostasis, regulating pain & inflammation, and extends into our nervous system and tissues, indicating its importance for many neurological conditions (Cameron, et al., 2020).
🌲
The study stated that cannabinoids target pain receptors offering relief and many women with fibromyalgia have been reported using cannabis and had relief from their chronic pain that is associated with their fibromyalgia (Cameron, et al., 2020).
♻️
Cheers to cannabinoids, their safety profile, & their effectiveness!
🐝🌲♻️
*This information is for educational purposes only. No medical advice or claims are being made :)
References
Berger, A. A., Keefe, J., Winnick, A., Gilbert, E., Eskander, J. P., Yazdi, C., Kaye, A. D., Viswanath, O., & Urits, I. (2020). Cannabis and cannabidiol (CBD) for the treatment of fibromyalgia. Best practice & research. Clinical anaesthesiology, 34(3), 617–631. https://doi.org/10.1016/j.bpa.2020.08.010
Cameron, E.C., Hemingway, S.L. Cannabinoids for fibromyalgia pain: a critical review of recent studies (2015–2019). J Cannabis Res 2, 19 (2020). https://doi.org/10.1186/s42238-020-00024-2
